N-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetamide, 98%, 5g

2,4-DIHYDROXY-5-ISOPROPYLBENZOIC ACID, 97.0%, 1g

(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide, 98.0%, 5mg

5-Methyl-2-(methylsulfonamido)benzoic acid, 95.0%, 250mg

1-(Sec-butyl)-2-nitrobenzene, 95+%, 1g

Microliter syringe MICROLITER® series 700 Point type 3, 100 µl, 710 NR, 1 piece

N-benzyl-4-piperidinecarboxamide hydrochloride, 95.0%, 5g

1-(4-Chloro-2-hydroxyphenyl)ethanone, 97.0%, 100g

1-(Pyridin-2-yl)-1H-1,2,3-benzotriazole, 50mg

N-(3-Chlorophenyl)-4-hydrazinyl-3-nitrobenzene-1-sulfonamide, 97%, 250mg

2-(2-Chloro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

1-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)ETHANAMINE HCL, 95.0%, 250mg

8-Methoxyquinoline>98.0%(GC)(T)1g